Idiopathic Pulmonary Arterial Hypertension Clinical Trial
Official title:
Feasibility Study of Empagliflozin as Treatment for Idiopathic Pulmonary Arterial Hypertension
The aim of the study is to determine whether conducting a randomized placebo-controlled clinical trial is feasible, safe for the patient and whether the treatment is well tolerated in patients with idiopathic pulmonary arterial hypertension.
This study is designed as a prospective, single-center, phase IIa, single-arm, open-label, interventional proof-of-concept trial in patients diagnosed with idiopathic pulmonary arterial hypertension (IPAH) who are currently on stable therapy. Patients will be administered a once-daily oral dose of 10 mg empagliflozin for a duration of 12 weeks along with standard treatment. The primary objective of this study is to assess safety and tolerability of empagliflozin and to assess whether a potential future randomized, double-blind, placebo-controlled study is feasible. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01884051 -
Hormonal, Metabolic, and Signaling Interactions in PAH
|
||
Completed |
NCT00626028 -
Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing
|
Phase 3 | |
Completed |
NCT02790450 -
Acute Effects of Benzbromaron on the Pulmonary Circulation
|
Phase 2 | |
Recruiting |
NCT05584722 -
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals
|
||
Completed |
NCT01590108 -
The Study of Apelin-APJ System on Pulmonary Hypertension Patients and Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT03933579 -
The PAH Platform for Deep Phenotyping in Korean Subjects
|
||
Completed |
NCT01613287 -
Proof of Concept Study of IMMUNOadsorption Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension
|
N/A | |
Recruiting |
NCT00372346 -
Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension
|
N/A | |
Withdrawn |
NCT01645826 -
Efficacy Study of Cardizem in Pulmonary Arterial Hypertension
|
N/A | |
Completed |
NCT00641836 -
Safety and Feasibility of Autologous Endothelial Progenitor Cells Transplantation in Patients With Idiopathic Pulmonary Arterial Hypertension
|
N/A | |
Not yet recruiting |
NCT06104228 -
129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
|
Phase 2 | |
Recruiting |
NCT02959723 -
Physiopathology of Pulmonary Arterial Hypertension: Mechanistic Studies
|
N/A | |
Recruiting |
NCT01288651 -
Iron Deficiency In Pulmonary Hypertension
|
Phase 4 | |
Recruiting |
NCT05462574 -
Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)
|
||
Completed |
NCT02565030 -
Chronic Thrombo-embolic Pulmonary Hypertension: Classification and Long Term Outcome
|
||
Active, not recruiting |
NCT01246037 -
Beta-blockers in i-PAH
|
Phase 1/Phase 2 | |
Recruiting |
NCT01683981 -
Exercise Capacity and Quality of Life in Patients With PPH Receiving Short Term Oral L-Citrulline Malate
|
Phase 0 | |
Completed |
NCT03069716 -
A Mobile Health Intervention in Pulmonary Arterial Hypertension
|
N/A | |
Completed |
NCT05767918 -
StratosPHere (Non-interventional Study)
|
||
Completed |
NCT00257413 -
Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension
|
N/A |